230 related articles for article (PubMed ID: 15713984)
1. Immunoglobulin replacement therapy in primary antibody deficiency diseases--maximizing success.
Durandy A; Wahn V; Petteway S; Gelfand EW
Int Arch Allergy Immunol; 2005 Mar; 136(3):217-29. PubMed ID: 15713984
[TBL] [Abstract][Full Text] [Related]
2. A new intravenous immunoglobulin (BIVIGAM®) for primary humoral immunodeficiency.
Wasserman RL
Expert Rev Clin Immunol; 2014 Mar; 10(3):325-37. PubMed ID: 24527947
[TBL] [Abstract][Full Text] [Related]
3. Modern management of primary B-cell immunodeficiencies.
Hoernes M; Seger R; Reichenbach J
Pediatr Allergy Immunol; 2011 Dec; 22(8):758-69. PubMed ID: 22122788
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin: a review.
Eibl MM; Wedgwood RJ
Immunodefic Rev; 1989; 1 Suppl():1-42. PubMed ID: 2698646
[TBL] [Abstract][Full Text] [Related]
5. [Replacement therapy with subcutaneous immunoglobulin in primary immunodeficiency in children].
Pac M
Pol Merkur Lekarski; 2011 Jun; 30(180):413-6. PubMed ID: 21751550
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: a mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies.
Bayry J; Fournier EM; Maddur MS; Vani J; Wootla B; Sibéril S; Dimitrov JD; Lacroix-Desmazes S; Berdah M; Crabol Y; Oksenhendler E; Lévy Y; Mouthon L; Sautès-Fridman C; Hermine O; Kaveri SV
J Autoimmun; 2011 Feb; 36(1):9-15. PubMed ID: 20970960
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin treatment in primary antibody deficiency.
Maarschalk-Ellerbroek LJ; Hoepelman IM; Ellerbroek PM
Int J Antimicrob Agents; 2011 May; 37(5):396-404. PubMed ID: 21276714
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin therapy: indications, potential side effects, and treatment guidelines.
Suez D
J Intraven Nurs; 1995; 18(4):178-90. PubMed ID: 7629638
[TBL] [Abstract][Full Text] [Related]
9. Neutropenia in antibody-deficient patients under IVIG replacement therapy.
Lemos S; Jacob CM; Pastorino AC; Castro AP; Fomin AB; Carneiro-Sampaio MM
Pediatr Allergy Immunol; 2009 Feb; 20(1):97-101. PubMed ID: 18373514
[TBL] [Abstract][Full Text] [Related]
10. [Intravenous immunoglobulin therapy].
Mouthon L
Rev Prat; 2005 May; 55(10):1049-56. PubMed ID: 16097244
[TBL] [Abstract][Full Text] [Related]
11. Hypogammaglobulinaemia.
Yong PF; Chee R; Grimbacher B
Immunol Allergy Clin North Am; 2008 Nov; 28(4):691-713, vii. PubMed ID: 18940570
[TBL] [Abstract][Full Text] [Related]
12. Use of intravenous immunoglobulin G (IVIG).
Looney RJ; Huggins J
Best Pract Res Clin Haematol; 2006; 19(1):3-25. PubMed ID: 16377538
[TBL] [Abstract][Full Text] [Related]
13. Nursing guidelines for administration of immunoglobulin replacement therapy.
Younger ME; Aro L; Blouin W; Duff C; Epland KB; Murphy E; Sedlak D;
J Infus Nurs; 2013; 36(1):58-68. PubMed ID: 23271153
[TBL] [Abstract][Full Text] [Related]
14. Subcutaneous administration of IgG.
Berger M
Immunol Allergy Clin North Am; 2008 Nov; 28(4):779-802, viii. PubMed ID: 18940574
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous immunoglobulin replacement therapy for primary antibody deficiency: advancements into the 21st century.
Moore ML; Quinn JM
Ann Allergy Asthma Immunol; 2008 Aug; 101(2):114-21; quiz 122-3, 178. PubMed ID: 18727465
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin G: trends in production methods, quality control and quality assurance.
Radosevich M; Burnouf T
Vox Sang; 2010 Jan; 98(1):12-28. PubMed ID: 19660029
[TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin: striving for appropriate use.
Kumar A; Teuber SS; Gershwin ME
Int Arch Allergy Immunol; 2006; 140(3):185-98. PubMed ID: 16682800
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of adverse events when changing intravenous immunoglobulin preparations.
Ameratunga R; Sinclair J; Kolbe J
Clin Exp Immunol; 2004 Apr; 136(1):111-3. PubMed ID: 15030521
[TBL] [Abstract][Full Text] [Related]
19. Intravenous gammaglobulin treatment in HIV-1 infection.
Deener A; Mehra A; Bernstein L; Shliozberg J; Rubinstein A
Immunol Allergy Clin North Am; 2008 Nov; 28(4):851-9, x. PubMed ID: 18940578
[TBL] [Abstract][Full Text] [Related]
20. Safety of intravenous immunoglobulin (IVIG) therapy.
Katz U; Achiron A; Sherer Y; Shoenfeld Y
Autoimmun Rev; 2007 Mar; 6(4):257-9. PubMed ID: 17317619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
